IDEXX Laboratories (NASDAQ:IDXX) Price Target Lowered to $570.00 at Barclays

IDEXX Laboratories (NASDAQ:IDXX – Get Free Report) had its price objective cut by research analysts at Barclays from $655.00 to $570.00 in a report released on Thursday, Benzinga reports. The firm currently has an “overweight” rating on the stock. Barclays‘s price objective points to a potential upside of 20.10% from the company’s current price. A […]

Related Keywords

Canada ,United States ,America ,Piper Sandler ,Asia Pacific ,William Blair ,Brianp Mckeon ,George Fennell ,Barclays ,Laboratories Company Profile ,Companion Animal Group ,Jpmorgan Chase Co ,Riverview Trust Co ,Wealth Management Group ,Goldman Sachs Group ,Capital Partners ,Securities Exchange Commission ,Valley National Advisers Inc ,Laboratories Inc ,Get Free Report ,Exchange Commission ,National Advisers ,Asset Management ,Private Wealth Management Group ,Latin America ,Water Quality Products ,